Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ablation Frontiers

2004 FOUNDED
M&A STATUS
801-900 EMPLOYEES
M&A LATEST DEAL TYPE
$225M LATEST DEAL AMOUNT
Description

Developer and marketer of cardiac ablation devices for the treatment of individuals suffering from atrial fibrillation and other cardiac arrhythmia. The company offers mapping and ablation catheters, RF generators, and accessories. It markets its cardiac ablation systems in the European Union and other international markets.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Acquirer
Primary Office
  • 2210 Faraday Avenue
  • Suite 100
  • Carlsbad, CA 92008
  • United States

+1 (760) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ablation Frontiers’s full profile, request a free trial.

Ablation Frontiers Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 12-Jan-2009 $225M 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 09-Jul-2007 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 23-Feb-2006 $15.1M $18.7M Completed Startup
1. Early Stage VC (Series A) 18-Jun-2004 $3.6M $3.6M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ablation Frontiers Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aberdare Ventures Venture Capital Minority 000 0000 000000 0
Affinity Capital Management Venture Capital Minority 000 0000 000000 0
Hexagon (Denver) PE/Buyout Minority 000 0000 000000 0
Longitude Capital Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »